A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | AA | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | # Insert your annotations below. Mouse-over the headers to see instructions. Contact maxh@ucsc.edu if you have questions on this form or suggestions. | ||||||||||||||||||||||||||
2 | # Note that the annotations do not go immediately to the public site, they are only made public once per day. To show the current version of the annotations track, click this link: | https://genome-test.gi.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&hubUrl=https://hgwdev.gi.ucsc.edu/~max/userAnnots/hub.txt | |||||||||||||||||||||||||
3 | Start | End | Label | Category | Long descriptive text | URL to website or paper with further info | Your email | ||||||||||||||||||||
4 | 1 | 450 | 5UTR | proteins | 5' UTR structured RNA | https://www.biorxiv.org/content/10.1101/2020.03.27.012906v1.full.pdf+html | jferna10@ucsc.edu | ||||||||||||||||||||
5 | 23605 | 23617 | furin_cleavage | proteins | Novel polybasic protein cleavage site (aa seq RRAR) that can be processed by furin-like proteases, not present in the virus from SARS 2013 outbreak, situated on the S1 side of site where a human protease cleaves viral S protein into S1 and S2 facilitating infection. See also http://www.chinaxiv.org/abs/202002.00062, https://www.nature.com/articles/s41591-020-0820-9.pdf, and news article https://www.nature.com/articles/d41586-020-00660-x. See https://www.biorxiv.org/content/10.1101/2020.04.10.036533v1.full.pdf for the structural interaction between the furin protein and this site on the viral S protein. | https://www.biorxiv.org/content/10.1101/2020.02.19.956581v1.full.pdf | haussler@ucsc.edu | ||||||||||||||||||||
6 | 22871 | 23086 | ACE2_receptor | proteins | receptor biding site motif in the virus S protein for the human ACE2 protein | https://www.nature.com/articles/s41422-020-0305-x | haussler@ucsc.edu | ||||||||||||||||||||
7 | 23923 | 23980 | fusion_peptide | proteins | fusion peptide in the viral S protein facilitating fusion of viral membrane with host cell membrane | https://www.nature.com/articles/s41422-020-0305-x | haussler@ucsc.edu | ||||||||||||||||||||
8 | 24289 | 24526 | Heptad_Repeat_1 | proteins | Heptad Repeat 1 (HR1), part of virus S protein that combines with HR2 to form a 6-helix bundle that brings viral and cellular membranes into close proximity for fusion and infection | https://www.nature.com/articles/s41422-020-0305-x | haussler@ucsc.edu | ||||||||||||||||||||
9 | 25045 | 25180 | Heptad_Repeat_2 | proteins | Heptad Repeat 2 (HR2), part of virus S protein that combines with HR1 to form a 6-helix bundle that brings viral and cellular membranes into close proximity for fusion and infection | https://www.nature.com/articles/s41422-020-0305-x | haussler@ucsc.edu | ||||||||||||||||||||
10 | 13467 | 13468 | -1_frame_shift | proteins | https://viralzone.expasy.org/860?outline=all_by_protein | haussler@ucsc.edu | |||||||||||||||||||||
11 | 28412 | 28433 | crRNA_N18f | CRISPR | CRISPR-Cas 13d guide for PAC-MAN viral inhibition strategy | https://www.biorxiv.org/content/10.1101/2020.03.13.991307v1.full | kiley.charbonneau@ucsf.edu, maureen.lewis@ucsf.edu, kord.kober@ucsf.edu | ||||||||||||||||||||
12 | 3271 | 3294 | Nsp3_gene_LB_+aln | primers | RT-LAMP primer ( + strand aln) | https://www.biorxiv.org/content/10.1101/2020.03.09.983064v2.full | kiley.charbonneau@ucsf.edu, maureen.lewis@ucsf.edu, kord.kober@ucsf.edu | ||||||||||||||||||||
13 | 3191 | 3214 | Nsp3_gene_LF_-aln | primers | RT-LAMP primer (- strand aln) | https://www.biorxiv.org/content/10.1101/2020.03.09.983064v2.full | kiley.charbonneau@ucsf.edu, maureen.lewis@ucsf.edu, kord.kober@ucsf.edu | ||||||||||||||||||||
14 | 3322 | 3345 | Nsp3_gene_B3_-aln | primers | RT-LAMP primer (- strand aln) | https://www.biorxiv.org/content/10.1101/2020.03.09.983064v2.full | kiley.charbonneau@ucsf.edu, maureen.lewis@ucsf.edu, kord.kober@ucsf.edu | ||||||||||||||||||||
15 | 3215 | 3219 | Nsp3_gene_FIP_-aln | primers | RT-LAMP primer (- strand aln) | https://www.biorxiv.org/content/10.1101/2020.03.09.983064v2.full | kiley.charbonneau@ucsf.edu, maureen.lewis@ucsf.edu, kord.kober@ucsf.edu | ||||||||||||||||||||
16 | 3241 | 3262 | Nsp3_gene_BIP_+aln | primers | RT-LAMP primer ( + strand aln) | https://www.biorxiv.org/content/10.1101/2020.03.09.983064v2.full | kiley.charbonneau@ucsf.edu, maureen.lewis@ucsf.edu, kord.kober@ucsf.edu | ||||||||||||||||||||
17 | 3302 | 3321 | Nsp3_gene_BIP_-aln | primers | RT-LAMP primer (- strand aln) | https://www.biorxiv.org/content/10.1101/2020.03.09.983064v2.full | kiley.charbonneau@ucsf.edu, maureen.lewis@ucsf.edu, kord.kober@ucsf.edu | ||||||||||||||||||||
18 | 22558 | 22600 | S309_binding_site | primers | Binding site for neutralizing antibody S309 | https://www.biorxiv.org/content/10.1101/2020.04.07.023903v2.full.pdf | jferna10@ucsc.edu | ||||||||||||||||||||
19 | 22621 | 22645 | S309_binding_site | primers | Binding site for neutralizing antibody S309 | https://www.biorxiv.org/content/10.1101/2020.04.07.023903v2.full.pdf | jferna10@ucsc.edu | ||||||||||||||||||||
20 | 22879 | 22894 | S309_binding_site | primers | Binding site for neutralizing antibody S309 | https://www.biorxiv.org/content/10.1101/2020.04.07.023903v2.full.pdf | jferna10@ucsc.edu | ||||||||||||||||||||
21 | 23044 | 23047 | S309_binding_site | primers | Binding site for neutralizing antibody S309 | https://www.biorxiv.org/content/10.1101/2020.04.07.023903v2.full.pdf | jferna10@ucsc.edu | ||||||||||||||||||||
22 | 28947 | 28954 | NES | proteins | Predicted Nuclear Export Signal, recently evolved in human and bat SARS-like viruses | https://www.biorxiv.org/content/10.1101/2020.04.05.026450v2 | haussler@ucsc.edu | ||||||||||||||||||||
23 | 29116 | 29125 | NLS | proteins | Predicted Nuclear Localization Signal, recently evolved in human and bat SARS-like viruses | https://www.biorxiv.org/content/10.1101/2020.04.05.026450v2 | haussler@ucsc.edu | ||||||||||||||||||||
24 | 29377 | 29395 | NLS | proteins | Predicted Nuclear Localization Signal, recently evolved in human and bat SARS-like viruses | https://www.biorxiv.org/content/10.1101/2020.04.05.026450v2 | haussler@ucsc.edu | ||||||||||||||||||||
25 | 29419 | 29440 | NLS | proteins | Predicted Nuclear Localization Signal, recently evolved in human and bat SARS-like viruses | https://www.biorxiv.org/content/10.1101/2020.04.05.026450v2 | haussler@ucsc.edu | ||||||||||||||||||||
26 | 29038 | 29050 | NLS | proteins | Predicted Nuclear Localization Signal, recently evolved in human and bat SARS-like viruses | https://www.biorxiv.org/content/10.1101/2020.04.05.026450v2 | haussler@ucsc.edu | ||||||||||||||||||||
27 | 22978 | 23020 | insertion | evolution | Evolutionarily recent insertion of new bases in human and bat SARS-like viruses, altered further in SARS-CoV-2 | https://www.biorxiv.org/content/10.1101/2020.04.05.026450v2 | haussler@ucsc.edu | ||||||||||||||||||||
28 | 24232 | 24244 | insertion | evolution | Evolutionarily recent insertion of new bases in human and bat SARS-like viruses | https://www.biorxiv.org/content/10.1101/2020.04.05.026450v2 | haussler@ucsc.edu | ||||||||||||||||||||
29 | 28880 | 28883 | 3subs | evolution | 3 consecutive base par substitutions in SARS-CoV-2, defining a subclade of Nextstrain Clade A2a | https://www.biorxiv.org/content/10.1101/2020.04.10.029454v1 | haussler@ucsc.edu | ||||||||||||||||||||
30 | 26394 | 26421 | BH3-like | proteins | BH3-like motif that is evolutionarily conserved. Predicted to bind members of the Bcl-2 protein family | https://www.biorxiv.org/content/10.1101/2020.04.09.033522v1.full.pdf | haussler@ucsc.edu | ||||||||||||||||||||
31 | 22666 | 22678 | CR3022_binding | antibodies | CR3022 is a neutralizing antibody against SARS1, has some affinity for SARS-CoV-2 | https://science.sciencemag.org/content/early/2020/04/02/science.abb7269 | jferna10@ucsc.edu | ||||||||||||||||||||
32 | 22681 | 22720 | CR3022_binding | antibodies | CR3022 is a neutralizing antibody against SARS1, has some affinity for SARS-CoV-2 | https://science.sciencemag.org/content/early/2020/04/02/science.abb7269 | jferna10@ucsc.edu | ||||||||||||||||||||
33 | 22726 | 22732 | CR3022_binding | antibodies | CR3022 is a neutralizing antibody against SARS1, has some affinity for SARS-CoV-2 | https://science.sciencemag.org/content/early/2020/04/02/science.abb7269 | jferna10@ucsc.edu | ||||||||||||||||||||
34 | 22735 | 22738 | CR3022_binding | antibodies | CR3022 is a neutralizing antibody against SARS1, has some affinity for SARS-CoV-2 | https://science.sciencemag.org/content/early/2020/04/02/science.abb7269 | jferna10@ucsc.edu | ||||||||||||||||||||
35 | 22840 | 22852 | CR3022_binding | antibodies | CR3022 is a neutralizing antibody against SARS1, has some affinity for SARS-CoV-2 | https://science.sciencemag.org/content/early/2020/04/02/science.abb7269 | jferna10@ucsc.edu | ||||||||||||||||||||
36 | 23104 | 23113 | CR3022_binding | antibodies | CR3022 is a neutralizing antibody against SARS1, has some affinity for SARS-CoV-2 | https://science.sciencemag.org/content/early/2020/04/02/science.abb7269 | jferna10@ucsc.edu | ||||||||||||||||||||
37 | 23116 | 23119 | CR3022_binding | antibodies | CR3022 is a neutralizing antibody against SARS1, has some affinity for SARS-CoV-2 | https://science.sciencemag.org/content/early/2020/04/02/science.abb7269 | jferna10@ucsc.edu | ||||||||||||||||||||
38 | 28958 | 28990 | N-gene_-aln | primers | Forward primer sequence for SARS-CoV-2 N-gene in AIOD-CRISPR Cas12a assay | https://www.biorxiv.org/content/10.1101/2020.03.19.998724v1.full.pdf | kiley.charbonneau@ucsf.edu, maureen.lewis@ucsf.edu, kord.kober@ucsf.edu | ||||||||||||||||||||
39 | 28870 | 28902 | N-gene_+aln | primers | Reverse primer sequence for SARS-CoV-2 N-gene in AIOD-CRISPR Cas12a assay | https://www.biorxiv.org/content/10.1101/2020.03.19.998724v1.full.pdf | kiley.charbonneau@ucsf.edu, maureen.lewis@ucsf.edu, kord.kober@ucsf.edu | ||||||||||||||||||||
40 | 28903 | 28922 | N-gene_crRNA_-aln | primers | N-gene crRNA target sequence used for AOID-CRISPR cas12a assay | https://www.biorxiv.org/content/10.1101/2020.03.19.998724v1.full.pdf | kiley.charbonneau@ucsf.edu, maureen.lewis@ucsf.edu, kord.kober@ucsf.edu | ||||||||||||||||||||
41 | 1 | 450 | 5'UTR_conserved | RNA | 5' UTR structured RNA found to be highly conserved among SARS-CoV-2 and other betacoronaviruses, potential target for antivirals | https://www.biorxiv.org/content/10.1101/2020.03.27.012906v1.full.pdf | kiley.charbonneau@ucsf.edu, maureen.lewis@ucsf.edu, kord.kober@ucsf.edu | ||||||||||||||||||||
42 | 29543 | 29903 | 3'UTR_conserved | RNA | 3' UTR structured RNA found to be highly conserved among SARS-CoV-2 and other betacoronaviruses, potential target for antivirals | https://www.biorxiv.org/content/10.1101/2020.03.27.012906v1.full.pdf | kiley.charbonneau@ucsf.edu, maureen.lewis@ucsf.edu, kord.kober@ucsf.edu | ||||||||||||||||||||
43 | 919 | 1038 | structuralRNA_conserved | RNA | Other highly conserved structural region for SARS-CoV-2 and other betacoronaviruses, a potential target for antivirals | https://www.biorxiv.org/content/10.1101/2020.03.27.012906v1.full.pdf | kiley.charbonneau@ucsf.edu, maureen.lewis@ucsf.edu, kord.kober@ucsf.edu | ||||||||||||||||||||
44 | 13459 | 13546 | frameshift_conserved | RNA | frameshift element structural RNA found to be highly conserved among SARS-CoV-2 and other betacoronaviruses | https://www.biorxiv.org/content/10.1101/2020.03.27.012906v1.full.pdf | kiley.charbonneau@ucsf.edu, maureen.lewis@ucsf.edu, kord.kober@ucsf.edu | ||||||||||||||||||||
45 | 10009 | 10035 | RNA_conserved | RNA | Unstructured conserved RNA common to SARS-CoV-2 and other betacoronaviruses. Unstructed conserved regions may be most easily targeted in primer-based diagnostic and oligonucleotide-based therapeutic strategies | https://www.biorxiv.org/content/10.1101/2020.03.27.012906v1.full.pdf | kiley.charbonneau@ucsf.edu, maureen.lewis@ucsf.edu, kord.kober@ucsf.edu | ||||||||||||||||||||
46 | 22918 | 22939 | GAGbinding_motif | proteins | Glycosaminoglycan binding motif experimentally and computationally predicted to bind heparin | https://www.biorxiv.org/content/10.1101/2020.04.14.041459v1 | haussler@ucsc.edu | ||||||||||||||||||||
47 | 23602 | 23620 | GAGbinding_motif | proteins | Glycosaminoglycan binding motif experimentally and computationally predicted to bind heparin | https://www.biorxiv.org/content/10.1101/2020.04.14.041459v1 | haussler@ucsc.edu | ||||||||||||||||||||
48 | 23584 | 23597 | deletion | evolution | common deletion in SARS-CoV-2 | http://virological.org/t/identification-of-a-common-deletion-in-the-spike-protein-of-sars-cov-2/451 | maxh@ucsc.edu | ||||||||||||||||||||
49 | 23596 | 23617 | deletion | evolution | common deletion in SARS-CoV-2 | http://virological.org/t/identification-of-a-common-deletion-in-the-spike-protein-of-sars-cov-2/451 | maxh@ucsc.edu | ||||||||||||||||||||
50 | 28566 | 28590 | Ngene_LF_-aln | primers | Ngene LAMP LF primer sequence (-aln) | https://www.biorxiv.org/content/10.1101/2020.04.20.048066v2.full.pdf | kiley.charbonneau@ucsf.edu, maureen.lewis@ucsf.edu, kord.kober@ucsf.edu | ||||||||||||||||||||
51 | 28654 | 28675 | Ngene_BIP_+aln | primers | Ngene LAMP BIP primer sequence (+aln) | https://www.biorxiv.org/content/10.1101/2020.04.20.048066v2.full.pdf | kiley.charbonneau@ucsf.edu, maureen.lewis@ucsf.edu, kord.kober@ucsf.edu | ||||||||||||||||||||
52 | 28605 | 28626 | Ngene_FIP_-aln | primers | Ngene LAMP FIP primer sequence (-aln) | https://www.biorxiv.org/content/10.1101/2020.04.20.048066v2.full.pdf | kiley.charbonneau@ucsf.edu, maureen.lewis@ucsf.edu, kord.kober@ucsf.edu | ||||||||||||||||||||
53 | 28676 | 28696 | Ngene_LB_+aln | primers | Ngene LAMP LB primer sequence (+aln) | https://www.biorxiv.org/content/10.1101/2020.04.20.048066v2.full.pdf | kiley.charbonneau@ucsf.edu, maureen.lewis@ucsf.edu, kord.kober@ucsf.edu | ||||||||||||||||||||
54 | 28722 | 28741 | Ngene_B3_-aln | primers | Ngene LAMP B3 primer sequence (-aln) | https://www.biorxiv.org/content/10.1101/2020.04.20.048066v2.full.pdf | kiley.charbonneau@ucsf.edu, maureen.lewis@ucsf.edu, kord.kober@ucsf.edu | ||||||||||||||||||||
55 | 26292 | 26354 | E_SECReTE_motif | RNA | SECReTE motif that facilitates mRNA localization to the ER, present more frequently in (+) ssRNA viruses which utilize ER membranes to create VRCs. Thought to be important for VRC formation by SARS-CoV-2, serves as a possible drug target. | https://www.biorxiv.org/content/10.1101/2020.04.20.050088v1.full | kiley.charbonneau@ucsf.edu, maureen.lewis@ucsf.edu, kord.kober@ucsf.edu | ||||||||||||||||||||
56 | 809 | 859 | nsp2_SECReTE_motif | RNA | SECReTE motif that facilitates mRNA localization to the ER, present more frequently in (+) ssRNA viruses which utilize ER membranes to create VRCs. Thought to be important for VRC formation by SARS-CoV-2, serves as a possible drug target. | https://www.biorxiv.org/content/10.1101/2020.04.20.050088v1.full | kiley.charbonneau@ucsf.edu, maureen.lewis@ucsf.edu, kord.kober@ucsf.edu | ||||||||||||||||||||
57 | 27791 | 27838 | Orf7b_SECReTE_motif | RNA | SECReTE motif that facilitates mRNA localization to the ER, present more frequently in (+) ssRNA viruses which utilize ER membranes to create VRCs. Thought to be important for VRC formation by SARS-CoV-2, serves as a possible drug target. | https://www.biorxiv.org/content/10.1101/2020.04.20.050088v1.full | kiley.charbonneau@ucsf.edu, maureen.lewis@ucsf.edu, kord.kober@ucsf.edu | ||||||||||||||||||||
58 | 14773 | 14817 | nsp12RdRp_SECReTE_motif | RNA | SECReTE motif that facilitates mRNA localization to the ER, present more frequently in (+) ssRNA viruses which utilize ER membranes to create VRCs. Thought to be important for VRC formation by SARS-CoV-2, serves as a possible drug target. | https://www.biorxiv.org/content/10.1101/2020.04.20.050088v1.full | kiley.charbonneau@ucsf.edu, maureen.lewis@ucsf.edu, kord.kober@ucsf.edu | ||||||||||||||||||||
59 | 21559 | 21597 | S_SECReTE_motif | RNA | SECReTE motif that facilitates mRNA localization to the ER, present more frequently in (+) ssRNA viruses which utilize ER membranes to create VRCs. Thought to be important for VRC formation by SARS-CoV-2, serves as a possible drug target. | https://www.biorxiv.org/content/10.1101/2020.04.20.050088v1.full | kiley.charbonneau@ucsf.edu, maureen.lewis@ucsf.edu, kord.kober@ucsf.edu | ||||||||||||||||||||
60 | 11011 | 11049 | nsp6_SECReTE_motif | RNA | SECReTE motif that facilitates mRNA localization to the ER, present more frequently in (+) ssRNA viruses which utilize ER membranes to create VRCs. Thought to be important for VRC formation by SARS-CoV-2, serves as a possible drug target. | https://www.biorxiv.org/content/10.1101/2020.04.20.050088v1.full | kiley.charbonneau@ucsf.edu, maureen.lewis@ucsf.edu, kord.kober@ucsf.edu | ||||||||||||||||||||
61 | 27147 | 27176 | M_SECReTE_motif | RNA | SECReTE motif that facilitates mRNA localization to the ER, present more frequently in (+) ssRNA viruses which utilize ER membranes to create VRCs. Thought to be important for VRC formation by SARS-CoV-2, serves as a possible drug target. | https://www.biorxiv.org/content/10.1101/2020.04.20.050088v1.full | kiley.charbonneau@ucsf.edu, maureen.lewis@ucsf.edu, kord.kober@ucsf.edu | ||||||||||||||||||||
62 | 14408 | 14409 | RdRp_missence | evolution | P->L point mutation in RdRp region adjacent to a target of many of the antivirals being used to treat COVID19 patients. Appearance of this mutation also coincides with a dramatic spike in COVID19 cases in Europe according to the WHO. | https://assets.researchsquare.com/files/rs-20304/v1/manuscript.pdf | kiley.charbonneau@ucsf.edu, maureen.lewis@ucsf.edu, kord.kober@ucsf.edu | ||||||||||||||||||||
63 | 23403 | 23404 | substitution | evolution | common missense mutation in SARS-CoV-2 with a notably high difference in resulting isoelectric point (D->G) | https://assets.researchsquare.com/files/rs-20304/v1/manuscript.pdf | kiley.charbonneau@ucsf.edu, maureen.lewis@ucsf.edu, kord.kober@ucsf.edu | ||||||||||||||||||||
64 | 28881 | 28882 | substitution | evolution | common double substitution in SARS-CoV-2 with a notably high difference in resulting isoelectric points (R->K) and (G->R) | https://assets.researchsquare.com/files/rs-20304/v1/manuscript.pdf | kiley.charbonneau@ucsf.edu, maureen.lewis@ucsf.edu, kord.kober@ucsf.edu | ||||||||||||||||||||
65 | 22660 | 22663 | V367F_substitution | V->F substitution isolated in the S protein RBD region which binds with human ACE2 receptors. Isolated in strains from Hong Kong and France and shown to reduce binding affinity | https://www.biorxiv.org/content/10.1101/2020.05.02.071811v1.full.pdf | kiley.charbonneau@ucsf.edu, maureen.lewis@ucsf.edu, kord.kober@ucsf.edu | |||||||||||||||||||||
66 | 22873 | 22876 | S438F_substitution | evolution | S->F substitution isolated in the S protein RBD region which binds with human ACE2 receptors. Isolated in strains from India, shown to reduce binding affinity. | https://www.biorxiv.org/content/10.1101/2020.05.02.071811v1.full.pdf | kiley.charbonneau@ucsf.edu, maureen.lewis@ucsf.edu, kord.kober@ucsf.edu | ||||||||||||||||||||
67 | 22987 | 22990 | G476S_substitution | evolution | G->S substitution isolated in the S protein RBD which binds with human ACE2 receptors. Isolated in strains from the US and Belgium, shown to reduce binding affinity | https://www.biorxiv.org/content/10.1101/2020.05.02.071811v1.full.pdf | kiley.charbonneau@ucsf.edu, maureen.lewis@ucsf.edu, kord.kober@ucsf.edu | ||||||||||||||||||||
68 | 23008 | 23011 | V483A_substitution | evolution | V->A substitution isolated in the S protein RBD which binds with human ACE2 receptors. Isolated in 16 strains unique to the US, shown to reduce binding affinity. | https://www.biorxiv.org/content/10.1101/2020.05.02.071811v1.full.pdf | kiley.charbonneau@ucsf.edu, maureen.lewis@ucsf.edu, kord.kober@ucsf.edu | ||||||||||||||||||||
69 | 28891 | 28912 | Ngene_BIP_+aln | primers | Ngene RT-LAMP primer sequence. This assay shows particularly promising speed and sensitivity | https://www.biorxiv.org/content/10.1101/2020.04.21.052530v1.article-info | kiley.charbonneau@ucsf.edu, maureen.lewis@ucsf.edu, kord.kober@ucsf.edu | ||||||||||||||||||||
70 | 28864 | 28885 | Ngene_FIP_-aln | primers | Ngene RT-LAMP primer sequence. This assay shows particularly promising speed and sensitivity | https://www.biorxiv.org/content/10.1101/2020.04.21.052530v1.article-info | kiley.charbonneau@ucsf.edu, maureen.lewis@ucsf.edu, kord.kober@ucsf.edu | ||||||||||||||||||||
71 | 28825 | 28845 | Ngene_LF_-aln | primers | Ngene RT-LAMP primer sequence. This assay shows particularly promising speed and sensitivity | https://www.biorxiv.org/content/10.1101/2020.04.21.052530v1.article-info | kiley.charbonneau@ucsf.edu, maureen.lewis@ucsf.edu, kord.kober@ucsf.edu | ||||||||||||||||||||
72 | 28987 | 29006 | Ngene_B3_-aln | primers | Ngene RT-LAMP primer sequence. This assay shows particularly promising speed and sensitivity | https://www.biorxiv.org/content/10.1101/2020.04.21.052530v1.article-info | kiley.charbonneau@ucsf.edu, maureen.lewis@ucsf.edu, kord.kober@ucsf.edu | ||||||||||||||||||||
73 | 22517 | 23185 | binds_47D11_Antibody | antibodies | Epitope of neutralizing antibody 47D11 | https://www.nature.com/articles/s41467-020-16256-y#Sec16 | maxh@ucsc.edu | ||||||||||||||||||||
74 | 23401 | 23404 | S_D614G | RNA | Mutation with 63.5% frequency across 16,087 whole genomes. Located near the spike RBD, and in a region with an epitope prediction score appx 34% above the median. | https://www.biorxiv.org/content/10.1101/2020.05.11.089409v1.full.pdf | kiley.charbonneau@ucsf.edu, maureen.lewis@ucsf.edu, kord.kober@ucsf.edu | ||||||||||||||||||||
75 | 28880 | 28885 | N_R203K_G204R | RNA | Two mutations with 18.8% frequency across 16,087 whole genomes within the nucleocapsid gene, a target antigen for several RDTs currently in use. Located within a region with both a high mutation rate and a high epitope prediction score (appx 30% above median). | https://www.biorxiv.org/content/10.1101/2020.05.11.089409v1.full.pdf | kiley.charbonneau@ucsf.edu, maureen.lewis@ucsf.edu, kord.kober@ucsf.edu | ||||||||||||||||||||
76 | 23403 | 23404 | spike_mutation | proteins | invasive spike protein variant (A->G at 23403, D614G) affects the spike S1/S2 furin-like site and modifies motion of the RBD | https://www.biorxiv.org/content/10.1101/2020.05.14.095620v1.full.pdf | kiley.charbonneau@ucsf.edu, maureen.lewis@ucsf.edu, kord.kober@ucsf.edu | ||||||||||||||||||||
77 | 28751 | 28816 | N_Bcell_epitope | antibodies | highly conserved B cell epitope in the N protein | https://www.biorxiv.org/content/10.1101/2020.05.14.095133v1.full.pdf | kiley.charbonneau@ucsf.edu, maureen.lewis@ucsf.edu, kord.kober@ucsf.edu | ||||||||||||||||||||
78 | 29147 | 29197 | N_Tcell_epitope | antibodies | highly conserved T cell epitope in the N protein | https://www.biorxiv.org/content/10.1101/2020.05.14.095133v1.full.pdf | kiley.charbonneau@ucsf.edu, maureen.lewis@ucsf.edu, kord.kober@ucsf.edu | ||||||||||||||||||||
79 | 24635 | 24685 | S_Bcell_epitope | antibodies | highly conserved B cell epitope in the S protein | https://www.biorxiv.org/content/10.1101/2020.05.14.095133v1.full.pdf | kiley.charbonneau@ucsf.edu, maureen.lewis@ucsf.edu, kord.kober@ucsf.edu | ||||||||||||||||||||
80 | 24593 | 24646 | S_Tcell_epitope | antibodies | highly conserved T cell epitope in the S protein | https://www.biorxiv.org/content/10.1101/2020.05.14.095133v1.full.pdf | kiley.charbonneau@ucsf.edu, maureen.lewis@ucsf.edu, kord.kober@ucsf.edu | ||||||||||||||||||||
81 | 23597 | 23626 | Del-Mut-1 | genes | 30bp deletion at the S1/S2 junction removes the PRRA motif from this region of the spike protein. Infection with this mutation in hamsters does not cause severe pathological changes associated with WT SARS-CoV-2 infection. Screening for this variant in asymptomatic cases could have important implications for Del-mut variants as an attenuated vaccine. | https://www.tandfonline.com/doi/full/10.1080/22221751.2020.1756700 | kiley.charbonneau@ucsf.edu, maureen.lewis@ucsf.edu, kord.kober@ucsf.edu | ||||||||||||||||||||
82 | 23297 | 23315 | nCOV-S-F1_primer | primers | qRT-PCR primer set for amplification and detection of S gene in WT and Del-Mut-1 variant SARS-CoV-2. R2 (WT) can be replaced with nCOV-S-R-MT ATGATGGATTGACTAGTCTG for detection of Del-Mut-1, a variant strain of SARS-CoV-2 with a 30bp deletion of the S1/S2 junction thought to attenuate infection severity | https://www.tandfonline.com/doi/full/10.1080/22221751.2020.1756701 | kiley.charbonneau@ucsf.edu, maureen.lewis@ucsf.edu, kord.kober@ucsf.edu | ||||||||||||||||||||
83 | 23659 | 23679 | nCOV-S-R1_primer | primers | qRT-PCR primer set for amplification and detection of S gene in WT and Del-Mut-1 variant SARS-CoV-2. R2 (WT) can be replaced with nCOV-S-R-MT ATGATGGATTGACTAGTCTG for detection of Del-Mut-1, a variant strain of SARS-CoV-2 with a 30bp deletion of the S1/S2 junction thought to attenuate infection severity | https://www.tandfonline.com/doi/full/10.1080/22221751.2020.1756702 | kiley.charbonneau@ucsf.edu, maureen.lewis@ucsf.edu, kord.kober@ucsf.edu | ||||||||||||||||||||
84 | 23462 | 23486 | nCOV-S-F2_primer | primers | qRT-PCR primer set for amplification and detection of S gene in WT and Del-Mut-1 variant SARS-CoV-2. R2 (WT) can be replaced with nCOV-S-R-MT ATGATGGATTGACTAGTCTG for detection of Del-Mut-1, a variant strain of SARS-CoV-2 with a 30bp deletion of the S1/S2 junction thought to attenuate infection severity | https://www.tandfonline.com/doi/full/10.1080/22221751.2020.1756703 | kiley.charbonneau@ucsf.edu, maureen.lewis@ucsf.edu, kord.kober@ucsf.edu | ||||||||||||||||||||
85 | 23603 | 23625 | nCOV-S-R2_primer | primers | qRT-PCR primer set for amplification and detection of S gene in WT and Del-Mut-1 variant SARS-CoV-2. R2 (WT) can be replaced with nCOV-S-R-MT ATGATGGATTGACTAGTCTG for detection of Del-Mut-1, a variant strain of SARS-CoV-2 with a 30bp deletion of the S1/S2 junction thought to attenuate infection severity | https://www.tandfonline.com/doi/full/10.1080/22221751.2020.1756704 | kiley.charbonneau@ucsf.edu, maureen.lewis@ucsf.edu, kord.kober@ucsf.edu | ||||||||||||||||||||
86 | 28967 | 29080 | N_Bcell_epitope | antibodies | Predicted B cell linear epitope in the N protein | https://www.biorxiv.org/content/10.1101/2020.05.16.100206v1.full | kiley.charbonneau@ucsf.edu, maureen.lewis@ucsf.edu, kord.kober@ucsf.edu | ||||||||||||||||||||
87 | 29072 | 29320 | N2b_evolution | proteins | Region of the N2b domain with several substitutions unique to SARS-CoV-2: A267, E290, Thr334, Asn345, Gln349. The N2b domain mediates homodimer formation in the N protein in all betacoronaviruses. | https://www.biorxiv.org/content/10.1101/2020.05.17.100685v1.full.pdf | kiley.charbonneau@ucsf.edu, maureen.lewis@ucsf.edu, kord.kober@ucsf.edu | ||||||||||||||||||||
88 | 1605 | 1607 | deletion | evolution | Common 3bp deletion of start codon (ATG), prevent expression of non-canonical transcript | http://virological.org/t/common-microdeletions-in-sars-cov-2-sequences/485 | kiley.charbonneau@ucsf.edu, maureen.lewis@ucsf.edu, kord.kober@ucsf.edu | ||||||||||||||||||||
89 | 516 | 518 | deletion | evolution | Common 3bp deletion of TTA, disrupt start codon | http://virological.org/t/common-microdeletions-in-sars-cov-2-sequences/485 | kiley.charbonneau@ucsf.edu, maureen.lewis@ucsf.edu, kord.kober@ucsf.edu | ||||||||||||||||||||
90 | 510 | 518 | deletion | evolution | Common 6bp deletion of GTCATGTTA, disrupts 2 start codons | http://virological.org/t/common-microdeletions-in-sars-cov-2-sequences/485 | kiley.charbonneau@ucsf.edu, maureen.lewis@ucsf.edu, kord.kober@ucsf.edu | ||||||||||||||||||||
91 | 28313 | 28372 | Nprot_seq1 | proteins | Peptide sequence within the SARS-CoV-2 N protein identified by mass spectrometry. RITFGGPSDSTGSNQNGERS. Mass spectrometry offers a promising possibility for more rapid and sensitive diagnostic tools as an alternative to PCR methods. | https://www.biorxiv.org/content/10.1101/2020.05.24.113043v1.full.pdf | kiley.charbonneau@ucsf.edu, maureen.lewis@ucsf.edu, kord.kober@ucsf.edu | ||||||||||||||||||||
92 | 28898 | 28954 | Nprot_seq2 | proteins | Peptide sequence within the SARS-CoV-2 N protein identified by mass spectrometry. RMAGNGGDAALALLLLDRL. Mass spectrometry offers a promising possibility for more rapid and sensitive diagnostic tools as an alternative to PCR methods. | https://www.biorxiv.org/content/10.1101/2020.05.24.113043v1.full.pdf | kiley.charbonneau@ucsf.edu, maureen.lewis@ucsf.edu, kord.kober@ucsf.edu | ||||||||||||||||||||
93 | 28718 | 28783 | Nprot_seq3 | proteins | Peptide sequence within the SARS-CoV-2 N protein identified by mass spectrometry. RNPANNAAIVLQLPQGTTLPKG. Mass spectrometry offers a promising possibility for more rapid and sensitive diagnostic tools as an alternative to PCR methods. | https://www.biorxiv.org/content/10.1101/2020.05.24.113043v1.full.pdf | kiley.charbonneau@ucsf.edu, maureen.lewis@ucsf.edu, kord.kober@ucsf.edu | ||||||||||||||||||||
94 | 23603 | 23614 | S_P681_RRA684 | proteins | Insertion unique to SARS-CoV-2 similar in structure and sequence to bacterial superantigens responsible for TSS, an immune response triggered by binding of these superantigens to MHCII molecules and TCRs. This motif is thought to be responsible for multisystem inflammatory syndrome in children associated with COVID-19, which induces similar pathology to TSS. | https://www.biorxiv.org/content/10.1101/2020.05.21.109272v1.full | kiley.charbonneau@ucsf.edu, maureen.lewis@ucsf.edu, kord.kober@ucsf.edu | ||||||||||||||||||||
95 | 24077 | 24079 | S_D839Y/N/E | proteins | recently reported mutation in a European strain of SARS-CoV-2 thought to strenghten the interaction responsible for multisystem inflammatory syndrome in children | https://www.biorxiv.org/content/10.1101/2020.05.21.109272v1.full | kiley.charbonneau@ucsf.edu, maureen.lewis@ucsf.edu, kord.kober@ucsf.edu | ||||||||||||||||||||
96 | 26302 | 26328 | Bcell_epitope | antibodies | B-cell epitope predicted as a universal candidate for peptide vaccine formation | https://www.biorxiv.org/content/10.1101/2020.05.26.115790v1 | kiley.charbonneau@ucsf.edu, maureen.lewis@ucsf.edu, kord.kober@ucsf.edu | ||||||||||||||||||||
97 | 26422 | 26439 | Tcell_epitope | antibodies | T-cell epitope predicted as a universal candidate for peptide vaccine formation | https://www.biorxiv.org/content/10.1101/2020.05.26.115790v2 | kiley.charbonneau@ucsf.edu, maureen.lewis@ucsf.edu, kord.kober@ucsf.edu | ||||||||||||||||||||
98 | 25524 | 25697 | ORF3c_OLG | genes | Previously unidentified gene that overlaps with codons 44-102 of ORF3a. Encodes a novel protein not present in other sarbecoronaviruses. Binds STOML2 mitochondrial protein and contains a signal peptide that may contribute to immune response as an antigenic target | https://www.biorxiv.org/content/10.1101/2020.05.21.109280v1.full#T1 | kiley.charbonneau@ucsf.edu, maureen.lewis@ucsf.edu, kord.kober@ucsf.edu | ||||||||||||||||||||
99 | 25563 | 25564 | G25563U | genes | mutation in the newly characterized ORF3c gene that causes loss of function, linked with ORF3a Q57H, commonly seen with RdRp P323L as well | https://www.biorxiv.org/content/10.1101/2020.05.21.109280v1.full#T2 | kiley.charbonneau@ucsf.edu, maureen.lewis@ucsf.edu, kord.kober@ucsf.edu | ||||||||||||||||||||
100 | 266 | 805 | ORF1ab_nsp1 | proteins | Non-structural Leader protein (NSP1) inhibits translation by binding to the 40S ribosomal subunit and induces a template-dependence endonucleolytic cleavage of host mRNAs. It also inhibits type I interferon expression and host antiviral signaling pathways, therefore inhibiting host innate immunity. | https://www.biorxiv.org/content/10.1101/2020.05.23.104919v1 | kiley.charbonneau@ucsf.edu, maureen.lewis@ucsf.edu, kord.kober@ucsf.edu |